PainReform Ltd (PRFX) stock is down -44.70% since Monday, August 31, 2020 when PRFX began trading, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PRFX stock a score of 30 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 0. PRFX's rank also includes a short-term technical score of 2. The fundamental score for PRFX is 88. In addition to the average rating from Wall Street analysts, PRFX stock has a mean target price of 10. This means analysts expect the stock to increase 173.97% over the next 12 months.
What's Happening with PRFX Stock Today
PainReform Ltd (PRFX) stock is lower by -9.87% while the S&P 500 is higher by 0.19% as of 1:48 PM on Tuesday, Apr 13. PRFX is down -$0.40 from the previous closing price of $4.05 on volume of 55,339 shares. Over the past year the S&P 500 has gained 18.16% while PRFX is down -44.70%. PRFX lost -$0.27 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on PainReform Ltd (PRFX) Stock.